The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dubow Adam since 2018.
This trader's CIK number is 1744507.
At the time of last reporting, Dubow Adam was the Gen Counsel & Secretary of Day One Biopharmaceuticals, Inc.. (stock ticker symbol DAWN).
Also see all insider trading activities at Day One Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DAWN | 0 | $0 | 13,563 | $113,603 | 36,259 | $0 |
| 2024 | DAWN | 0 | $0 | 12,862 | $188,371 | 33,596 | $0 |
| 2023 | DAWN | 0 | $0 | 5,313 | $62,108 | 13,600 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | BMY | 0 | $0 | 5,585 | $367,711 | 5,404 | $0 |
| 2020 | BMY | 0 | $0 | 4,100 | $252,283 | 5,007 | $0 |
| 2019 | BMY | 0 | $0 | 1,740 | $102,329 | 3,735 | $0 |
| 2018 | BMY | 0 | $0 | 0 | $0 | 797 | $0 |
1. Day One Biopharmaceuticals, Inc. (DAWN)
2. Bristol Myers Squibb Co (BMY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | DAWN | Sale | 4,365 | 6.77 | 29,537 |
| 2025-08-15 | DAWN | Option Ex | 12,087 | .00 | 0 |
| 2025-05-16 | DAWN | Sale | 4,552 | 6.26 | 28,486 |
| 2025-05-15 | DAWN | Option Ex | 12,086 | .00 | 0 |
| 2025-02-18 | DAWN | Sale | 4,646 | 11.96 | 55,580 |
| 2025-02-15 | DAWN | Option Ex | 12,086 | .00 | 0 |
| 2024-11-18 | DAWN | Sale | 3,165 | 13.21 | 41,809 |
| 2024-11-15 | DAWN | Option Ex | 8,399 | .00 | 0 |
| 2024-08-16 | DAWN | Sale | 3,202 | 14.00 | 44,824 |
| 2024-08-15 | DAWN | Option Ex | 8,399 | .00 | 0 |
| 2024-05-16 | DAWN | Sale | 3,253 | 16.08 | 52,304 |
| 2024-05-15 | DAWN | Option Ex | 8,399 | .00 | 0 |
| 2024-02-15 | DAWN | Option Ex | 8,399 | .00 | 0 |
| 2024-02-16 | DAWN | Sale | 3,242 | 15.25 | 49,434 |
| 2023-11-15 | DAWN | Option Ex | 13,600 | .00 | 0 |
| 2023-11-16 | DAWN | Sale | 5,313 | 11.69 | 62,108 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-30 | BMY | Sale | 2,466 | 67.90 | 167,441 |
| 2021-05-05 | BMY | Sale | 3,119 | 64.21 | 200,270 |
| 2021-03-10 | BMY | Option Ex | 5,404 | .00 | 0 |
| 2020-11-24 | BMY | Sale | 900 | 63.39 | 57,051 |
| 2020-05-22 | BMY | Sale | 3,200 | 61.01 | 195,232 |
| 2020-03-10 | BMY | Option Ex | 5,007 | .00 | 0 |
| 2019-12-05 | BMY | Sale | 1,740 | 58.81 | 102,329 |
| 2019-03-10 | BMY | Option Ex | 3,735 | .00 | 0 |
| 2018-09-03 | BMY | Option Ex | 797 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dubow Adam (Gen Counsel & Secretary of Day One Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.